Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $6.7 million.

  • Beam Therapeutics' Other Non-Current Assets rose 163.38% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 163.38%. This contributed to the annual value of $8.1 million for FY2024, which is 659.48% down from last year.
  • As of Q3 2025, Beam Therapeutics' Other Non-Current Assets stood at $6.7 million, which was up 163.38% from $6.6 million recorded in Q2 2025.
  • Beam Therapeutics' 5-year Other Non-Current Assets high stood at $15.4 million for Q2 2023, and its period low was $6.2 million during Q2 2024.
  • Over the past 5 years, Beam Therapeutics' median Other Non-Current Assets value was $9.8 million (recorded in 2023), while the average stood at $10.4 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 2099.48% in 2023, then crashed by 6009.6% in 2024.
  • Quarter analysis of 5 years shows Beam Therapeutics' Other Non-Current Assets stood at $12.7 million in 2021, then rose by 0.06% to $12.8 million in 2022, then plummeted by 31.64% to $8.7 million in 2023, then fell by 6.59% to $8.1 million in 2024, then decreased by 18.27% to $6.7 million in 2025.
  • Its Other Non-Current Assets stands at $6.7 million for Q3 2025, versus $6.6 million for Q2 2025 and $6.6 million for Q1 2025.